Conference Proceedings

Phase 1b Trial of LTI-01 (Single Chain Urokinase Plasminogen Activator, scuPA) Intrapleural Fibrinolytic Therapy (IPFT) in Patients with Complicated Parapneumonic Effusions (CPE) or Empyema

S Idell, LEL Beckert, B Brockway, G Simpson, AM Southcott, YCG Lee, NM Rahman, RW Light, S Shoemaker, JD Gillies, AA Komissarov, G Florova, K Sarva

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | AMER THORACIC SOC | Published : 2019

DOI: 10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a4342

University of Melbourne Researchers

Grants

Awarded by NIH SMARTT

Awarded by NIH

Funding Acknowledgements

This abstract is funded by: Lung Therapeutics, Inc. (LTI), NIH SMARTT HHSN268201100014C(SI) and NIH UO-1 HL121841-01A1(SI).

Keywords

General & Internal Medicine
Respiratory System
Clinical Trials and Supportive Activities
3201 Cardiovascular Medicine and Haematology
Science & Technology
3202 Clinical Sciences
32 Biomedical and Clinical Sciences
Critical Care Medicine
Life Sciences & Biomedicine
Infectious Diseases
Clinical Research